Please assess the completion status of the following clinical trial:

Trial Title: Observational Study to Evaluate the Safety of Levemir® in Diabetes

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age according to approved label in each country and physician discretion~* Type 1 or 2 diabetes~* Recently started treatment with insulin detemir at the discretion of the investigator. Before initiation of insulin detemir they should not have been treated with insulin~* Selection at the discretion of the physician~Exclusion Criteria:~* Current treatment with Levemir® (insulin detemir)~* Previously enrolled in the study~* Hypersensitivity to Levemir® (insulin detemir)

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Type 1 diabetes (Type: None): Prescription of insulin detemir (Levemir®) according to local approved labelling by prescribing physician in a normal clinical practice to patients with type 1 diabetes, including newly diagnosed patients who have never received insulin or analogue treatment.
- Type 2 diabetes (Type: None): Prescription of insulin detemir (Levemir®) according to local approved labelling by prescribing physician in a normal clinical practice to patients with type 1 diabetes, including newly diagnosed patients who have never received insulin or analogue treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).